Related Experiment Video
Updated: Apr 6, 2026

07:32
Author Spotlight: 3D Movement Assessment of Maxillary Posterior Teeth in Clear Aligner Treatment
Published on: February 23, 2024
2.1K
Clear aligners: between clinical inertia and dormant disruption
European Journal of Orthodontics
|April 4, 2026
Summary
Innovations in clear aligner attachments, bonding, and materials are needed to improve clinical efficiency and enamel preservation. This review explores advances like debond-on-demand adhesives to enhance aligner therapy predictability.
Area of Science:
- Biomaterials Science
- Orthodontics
- Dental Materials
Background:
- Clear aligner therapy has seen rapid growth but faces limitations in clinical efficiency, biomechanical predictability, and enamel preservation.
- Current attachments, bonding protocols, and aligner materials restrict advancements despite increased research and market proliferation.
Purpose of the Study:
- To review potential biomedical innovations for clear aligner therapy.
- To provide a roadmap for translating new technologies into clinical practice.
- To address limitations in force delivery, attachment debonding, and material design.
Main Methods:
- Literature review focusing on recent advancements in dental adhesives and material science.
- Analysis of prepolymerized attachment materials, non-etch bonding strategies, and novel polymer technologies.
- Evaluation of strategies for reversible adhesion and enamel preservation.
Main Results:
- Potential advances include prepolymerized attachments, non-etch bonding, debond-on-demand adhesives, and biomimetic materials.
- Nondissipative energy polymers offer possibilities for improved force delivery.
- Strategies focus on minimizing stress relaxation and enabling on-demand adhesion.
Conclusions:
- Translating biomedical innovations can significantly enhance clear aligner therapy performance and predictability.
- Focus on enamel preservation, controlled adhesion, and material innovation is crucial.
- Future developments should aim for reversible adhesion and improved biomechanical control.
Related Concept Videos
Blinding
4.1K
Blinding is a commonly used method of not telling participants which treatment a subject is receiving. Blinding is a critical part of a randomized control trial or RCT. It reduces the bias that affects the results. In an RCT, blinding is used in the form of a placebo. A placebo effect occurs when untreated subjects falsely believe they have received the treatment and report improved symptoms. A placebo or a dummy treatment is administered to subjects to negate the bias caused by such an effect.
4.1K
ortho–para-Directing Deactivators: Halogens
7.1K
Halogens are ortho–para directors. They are more electronegative than carbon. Therefore, as ring substituents, they can withdraw electrons through the inductive effect and deactivate the aromatic ring towards electrophilic substitution. Halogens also have an electron-donating resonance effect on the ring, which influences the orientation of the incoming electrophile. If an electrophile attacks at the ortho or the para position, the halogen donates electrons and stabilizes the intermediate...
7.1K
Clinical Trials: Overview
5.5K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.5K

